Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Oncolytics Biotech Inc T.ONC

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  ONCY

Oncolytics Biotech, Inc., is a development stage biopharmaceutical company that focuses on the discovery and development of pharmaceutical products for the treatment of cancers.
Price: $0.54 | Change: $-0.01 | %Change: -1.82%
Volume: 81,061 | Day High/Low: 0.57/0.53 | 52 Week High/Low: 2.99/0.445
View modes: 
5 stars


The recent downturn appears to be a little over the top and has punished the company share price beyond belief. I think that the bottom is in now and should begin to gain back some of the more
4.5 stars


The recent trial results are depressing for those of us who had high hopes for viral oncolytic therapy. One could argue that it's "just one trial", but this was basically the best case scenario more
0 stars

Seeking Alpha in the chance that the information regarding Reolysin isn't wrong - that Reolysin is actually a more
0 stars


The risks and dangers of biotechs. Bought @ $1.50. OUCH. Another one where relying on anal-cysts can kill you.  rate and reply
0 stars

Target Prices

Targets are still encouraging.  $1.60, $2.50, $4, etc. Still some optimism out there. Can't really trust analcysts but still... "a deeper look at the data is suggestive of a positive more
0 stars


numbers aren't that high but quite a few people are packing it in with ONC. ITG sold 18,000 shares in the final minutes of trading. Not looking very positive. It's been a long 16 years. It just more
0 stars

Quick fact about ONC

Oncolytics Biotech (NASDAQ:ONCY) last issued its quarterly earnings data on Thursday, August 7th. The company reported ($0.05) earnings per share for the quarter, beating the analysts’ more
0 stars

ONC - 4.00 PT with a "BUY" rating!!!!!!!!!!!!  rate and reply
0 stars

The sky is not falling chicken little

Oncolytics did present additional data for a subgroup of patients with a certain gene mutation known as KRAS. In this patient population, the REOLYSIN arm showed a small benefit in progression more
0 stars

RE:This is why I'm in - NEW ARTICLE!!!!

BaystreetBrian wrote: I saw that more
5 stars

This is why I'm in - NEW ARTICLE!!!!  rate and reply
5 stars


Birch....we must share a mind, cuz you took my thoughts and typed them you, I'm in!  rate and reply
5 stars


LOL, they just started the next testing for Ovarian Cancer.  Some promise for sure on the last one, so, I took some today and will stick around.  Especially, because, if the news was that bad, I more
1 star


ONC is all but finished. Get what is left of your investment now....on its way to pennies. SELL!  rate and reply
5 stars


Someone pointed me here this morning.  Not sure why the panic with only 1% of the float dumped.  Seems like it is the end of the world or something, but not when you look at volume. GL  rate and reply
0 stars


This was put out yesterday and released this morning. Paradigm Capital Reaffirms Buy Rating for Oncolytics Biotech (ONC) Posted by Logan Wallace on Sep 17th, 2014 // No Comments more
0 stars


Drop it like its hot.    It`s been downgraded by some analysts and the results from it`s latest clinical trials were underwhelming.  rate and reply
4 stars


Time ET Ex Price Change Volume Buyer Seller Markers 09:35:09 T 0.94 -0.46 50 2 RBC more
2 stars

RE:RE:Answers, Issues, Questions

Bunge, With 10K shares, you might get to $100G in six months! Lots of news coming up, including panc results in less than two weeks. Its getting the $1 mil that might take 2-3 years. WC  rate and reply
0 stars

RE:Fund Security

Oncy has cash on hand sufficient until October 2015. The float is relatively small and the company has always had the ability to raise cash when needed. After the end of September, the share price more

How to invest in private equity without writing a $1 million check.

Click here to watch the video